Laura Brege - Net Worth and Insider Trading

Laura Brege Net Worth

The estimated net worth of Laura Brege is at least $724,503 dollars as of 2024-06-08. Laura Brege is the Director of Pacira BioSciences Inc and owns about 9,547 shares of Pacira BioSciences Inc (PCRX) stock worth over $272,758. Laura Brege is the Director of Mirum Pharmaceuticals Inc and owns about 10,000 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $250,700. Laura Brege is also the Director of ACADIA Pharmaceuticals Inc and owns about 13,502 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $201,045. Details can be seen in Laura Brege's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Laura Brege has not made any transactions after 2023-06-12 and currently still holds the listed stock(s).

Transaction Summary of Laura Brege

To

Laura Brege Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Laura Brege owns 9 companies in total, including Portola Pharmaceuticals Inc (PTLA) , ACADIA Pharmaceuticals Inc (ACAD) , and Mirum Pharmaceuticals Inc (MIRM) among others .

Click here to see the complete history of Laura Brege’s form 4 insider trades.

Insider Ownership Summary of Laura Brege

Ticker Comapny Transaction Date Type of Owner
PTLA Portola Pharmaceuticals Inc 2020-07-02 director
ACAD ACADIA Pharmaceuticals Inc 2023-06-12 director
MIRM Mirum Pharmaceuticals Inc 2019-09-10 director
LIMIT LIMIT 2023-06-05 director
LIMIT LIMIT 2015-02-05 director
LIMIT LIMIT 2018-07-27 director
LIMIT LIMIT 2012-07-05 director
LIMIT LIMIT 2009-12-10 director
LIMIT LIMIT 2021-03-25 director

Laura Brege Latest Holdings Summary

Laura Brege currently owns a total of 3 stocks. Among these stocks, Laura Brege owns 9,547 shares of Pacira BioSciences Inc (PCRX) as of June 5, 2023, with a value of $272,758 and a weighting of 37.65%. Laura Brege owns 10,000 shares of Mirum Pharmaceuticals Inc (MIRM) as of September 10, 2019, with a value of $250,700 and a weighting of 34.6%. Laura Brege also owns 13,502 shares of ACADIA Pharmaceuticals Inc (ACAD) as of June 12, 2023, with a value of $201,045 and a weighting of 27.75%.

Latest Holdings of Laura Brege

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCRX Pacira BioSciences Inc 2023-06-05 9,547 28.57 272,758
MIRM Mirum Pharmaceuticals Inc 2019-09-10 10,000 25.07 250,700
ACAD ACADIA Pharmaceuticals Inc 2023-06-12 13,502 14.89 201,045

Holding Weightings of Laura Brege


Laura Brege Form 4 Trading Tracker

According to the SEC Form 4 filings, Laura Brege has made a total of 4 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 600 shares on June 5, 2023, which brought Laura Brege around $23,244.

According to the SEC Form 4 filings, Laura Brege has made a total of 1 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 10,000 shares on September 10, 2019, which cost Laura Brege around $112,200.

According to the SEC Form 4 filings, Laura Brege has made a total of 3 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 4,500 shares on June 12, 2023, which brought Laura Brege around $111,915.

Insider Trading History of Laura Brege

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Laura Brege Trading Performance

GuruFocus tracks the stock performance after each of Laura Brege's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laura Brege is -5.99%. GuruFocus also compares Laura Brege's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laura Brege within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Laura Brege's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Laura Brege

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.37 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.99 LIMIT LIMIT LIMIT LIMIT LIMIT

Laura Brege Ownership Network

Ownership Network List of Laura Brege

No Data

Ownership Network Relation of Laura Brege

Insider Network Chart

Laura Brege Owned Company Details

What does Portola Pharmaceuticals Inc do?

Who are the key executives at Portola Pharmaceuticals Inc?

Laura Brege is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .

Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Portola Pharmaceuticals Inc Insider Transactions

No Available Data

Laura Brege Mailing Address

Above is the net worth, insider trading, and ownership report for Laura Brege. You might contact Laura Brege via mailing address: C/o Onyx Pharmaceuticals, Inc., 2100 Powell Street, Emeryville Ca 94608.

Discussions on Laura Brege

No discussions yet.